The Global report on “Stem Cell Assay Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report also details the information about the global market status, growth rate, future trends, market drivers, challenges, opportunities and porter’s forces analysis with respect to these elements. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=709722
“The global stem cell assay market projected to grow at a CAGR of 20.1% during the forecast period.”
The stem cell assay market is expected to reach USD 1,978.7 million by 2023 from USD 791.9 million in 2018, at a CAGR of 20.1%. The availability of funding for stem cell research; rising incidence of target indications; technological advancements in stem cell research instruments and the introduction of novel stem cell products; and the growth of end-use industries are the major factors driving the growth of this market. On the other hand, ethical issues related to embryonic stem cell research and the high cost of stem cell analysis instruments and reagents are factors expected to restrain the growth of this market to a certain extent.
“By type, the isolation & purification segment is anticipated to grow at the highest growth rate during the forecast period.”
This market is categorized by type into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The isolation & purification segment is estimated to grow at the highest rate during the forecast period. The rising demand for stem cell isolation assays in biotechnology and biopharmaceutical companies for drug development processes is driving the growth of this segment.
“Biopharmaceutical& biotechnology companies to dominate the end-user market during the forecast period.”
By end user, the stem cell assay market is segmented into biopharmaceutica l& biotechnology companies; and research institutes. The biopharmaceutical& biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. Stem cell assays are widely used by biopharmaceutical & biotechnology companies for drug screening and development and cell analysis, which is the key factor driving the growth of this end-user segment in this market.
“North America is estimated to grow at the highest CAGR during the study period.”
In 2017, the stem cell assay market was dominated by North America; and also estimated to grow at the Highest growth rate during the forecast period. The growth of this segment can be attributed to the increasing availability of grants and funding from governments as well as the rising use of stem cells for personalized medicine and drug discovery & development. Moreover, the growth of the biotechnology and pharmaceutical industry and rising incidence of cancer are also contributing to market growth in North America.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type – Tier 1 – 60%, Tier 2 – 20% and Tier 3 – 20%
- By Designation – C-level – 40%, Director-level – 20%, Others – 40%
- By Region – North America –50%, Europe – 20%, Asia Pacific– 30%
The key players in the stem cell assay market include Merck (Germany), GE Healthcare (US), Agilent Technologies (US), Thermo Fisher Scientific (US),Bio-Rad Laboratories (US), Cell Biolabs (US), PerkinElmer (US),Promega Corporation (US), Miltenyi Biotec (Germany), Bio-Techne Corporation (US), HemoGenix (US), STEMCELL Technologies (Canada), and Cellular Dynamics International (US).
Research Coverage:
The report analyses the stem cell assay market by type, cell type, product & service, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms to garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthen their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the stem cell assay market
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the stem cell assay market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the stem cell assay market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various stem cell assays across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the stem cell assay market.
More information about Discount offers (20% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=709722
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441